OpenVSafe by OpenVAERS
Search V-safe

CD7-26872-36010

2 vaccinations 2 coded responses 3 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
300 / GA
Registered
2021-06-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-26
    Registered in v-safe
  3. 2021-06-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-06-27
    Dose 2 — Pfizer-BioNTech
  5. 2021-06-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: Insomnia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Conjunctivitis — Feeling: Fair
    Free text: May be unrelated, but I developed an unexplained case of pink eye
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-06-06Pfizer-BioNTech No
22021-06-27Pfizer-BioNTech No

Free text

Release 9 — days 1–6 daily, dose 2

2021-06-28

Systemic reaction (other): Insomnia

2021-06-29

Systemic reaction (other): May be unrelated, but I developed an unexplained case of pink eye

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROConjunctivitis ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…